Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease

This publication has 37 references indexed in Scilit:

• Urotensin II in the cardiovascular system
  Peptides, 2004
• Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries
  Peptides, 2004
• Differential Effect of Urotensin II on Vascular Tone in Normal Subjects and Patients With Chronic Heart Failure
  Circulation, 2004
• Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy
  International Journal of Cardiology, 2004
• Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats
  Canadian Journal of Physiology and Pharmacology, 2004
• Increased plasma urotensin II levels in patients with diabetes mellitus
  Clinical Science, 2003
• Urotensin II evokes potent vasoconstriction in humans in vivo
  British Journal of Pharmacology, 2002
• Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14
  Biochemical and Biophysical Research Communications, 1999
• Martingale-based residuals for survival models
  Biometrika, 1990
• Partial residuals for the proportional hazards regression model
  Biometrika, 1982